GMP IPO Watch
Speciality Medicines IPO Closing Today: A Deep Value Pharma Play or a Quiet SME Debut?
Mumbai-based Speciality Medicines Limited wraps up its ₹29.14 crore SME IPO today, March 2...
Read Article
S
SME IPO
LISTED
NSE, BSE
SPECIALITYMEDICINES
Speciality Medicines IPO
Speciality Medicines IPO details, live grey market premium (GMP), dates, price band, lot size, subscription & review.
Live GMP Today
₹0
+0.0%
Est. Listing: ₹124.00
Price Band
₹117 - ₹124
Per equity share
Lot Size
1000 Shares
Min Invest: ₹2,48,000
Issue Size
₹124 Cr
Total Public Offering
Issue Dates
19 March 2026 – 23 March 2026
Bidding period
Subscription
2.27x
Total overall demand
Speciality Medicines IPO Details
Key facts at a glance| IPO Open Date | 19 March 2026 | IPO Close Date | 23 March 2026 |
|---|---|---|---|
| Basis of Allotment | TBA | Listing Date | 29 March 2026 |
| Price Band | ₹117 - ₹124 per share | Face Value | ₹10 per share |
| Market Lot Size | 1000 Shares | Min Investment (Retail) | ₹2,48,000 |
| Total Issue Size | ₹124 Cr | Issue Type | Book Built Issue IPO |
| Fresh Issue | — | Offer for Sale (OFS) | — |
| Listing At | NSE, BSE | Issue Category | SME Issue |
| Registrar | TBA | ||
Speciality Medicines IPO Timetable (Tentative Dates)
| Event | Tentative Date | Status |
|---|---|---|
| IPO Open Date | 19 March 2026 | Confirmed |
| IPO Close Date | 23 March 2026 | Confirmed |
| Basis of Allotment | TBA | Tentative |
| Initiation of Refunds | TBA | Tentative |
| Credit of Shares to Demat | TBA | Tentative |
| IPO Listing Date | 29 March 2026 | Tentative |
| Cut-off time for UPI Mandate Confirmation | 5:00 PM on Closing Day | Deadline |
* Note: Timelines are tentative and subject to regulatory confirmation. UPI mandate approvals must be completed by 5:00 PM on the IPO closing day.
Speciality Medicines IPO Lot Size & Investment Details
Application limits for Retail and HNI investors| Application Category | Lots | Shares | Amount (at Cut-off) |
|---|---|---|---|
| Retail (Min) | 2 Lots | 2,000 Shares | ₹2,48,000 |
| Retail (Max) | 2 Lots | 2,000 Shares | ₹2,48,000 |
| S-HNI (Min) | 3 Lots | 3,000 Shares | ₹3,72,000 |
| S-HNI (Max) | 8 Lots | 8,000 Shares | ₹9,92,000 |
| B-HNI (Min) | 9 Lots | 9,000 Shares | ₹11,16,000 |
Speciality Medicines IPO Live GMP & Movement History
Daily unofficial grey market trends
Current Grey Market Premium
₹0 +0.0%
Estimated Listing Price
₹124.00
| Date | IPO GMP (₹) | Estimated Listing Price | Estimated Listing Gain (%) |
|---|---|---|---|
| 26 Mar 2026 | ₹0 | ₹124.00 | +0.00% |
| 24 Mar 2026 | ₹0 | ₹124.00 | +0.00% |
| 23 Mar 2026 | ₹0 | ₹124.00 | +0.00% |
| 18 Mar 2026 | ₹0 | ₹124.00 | +0.00% |
Disclaimer: Grey Market Premium (GMP) figures are purely unofficial and indicative rates traded in the unregulated grey market. GMP is highly volatile and does not guarantee the actual listing price. Always consult a SEBI registered investment advisor before bidding.
Speciality Medicines IPO Subscription Status
Demand breakdown by investor category
Retail
0.85x
QIB
96.24x
NII / HNI
—
Total
2.27x
About Speciality Medicines
Speciality Medicines IPO is an SME public issue of a pharmaceutical company engaged in the marketing and distribution of specialty medicines, including high-cost drugs used for chronic and complex diseases. The IPO aims to raise funds primarily for business expansion and working capital needs. The issue opened on 20 March 2026 and is expected to raise around ₹29 crore, with a neutral grey market sentiment (GMP ~ ₹0) indicating cautious investor interest before listing. With growing demand for advanced healthcare treatments and specialty drugs, the company operates in a niche but expanding segment of the pharmaceutical industry, offering potential long-term growth opportunities.
Speciality Medicines IPO Reservation & Share Quotas
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | — Shares | —% |
| QIB (Ex. Anchor) | — Shares | 2% |
| NII Shares Offered | — Shares | 49% |
| Retail Shares Offered | — Shares | 49% |
Speciality Medicines IPO Anchor Investors
| Anchor Bidding Date | 2026 |
|---|---|
| Shares Offered | — Shares |
| Anchor Size | — Cr. |
| Lock-in Period (50% Shares - 30 Days) | 2026 |
| Lock-in Period (50% Shares - 90 Days) | 2026 |
Speciality Medicines IPO Important Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 20 Mar 2026 |
| IPO Close Date | 24 Mar 2026 |
| Basis of Allotment | - |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 30 Mar 2026 |
Note: The timeline for विशेष औषधे IPO is tentative and subject to change.
Speciality Medicines Promoters and Shareholding Pattern
| Promoters | Parth B Goyani and Goyani Sumit Babubhai |
|---|---|
| Promoter Holding Pre Issue | 64,35,796 Shares (59.28%) |
| Promoter Holding Post Issue | 87,85,796 Shares (43.44%) |
Speciality Medicines Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Speciality Medicines Company Financial Report
To Be Updated Soon
Speciality Medicines Company Valuation & Key Performance Indicators
To Be Updated Soon
Speciality Medicines Peer Group Comparison
To Be Updated Soon
Speciality Medicines Lead Managers & Merchant Bankers
- Unicon Capital Services Pvt. Ltd.
Speciality Medicines IPO FAQs
Speciality Medicines IPO opens for subscription on 19 March 2026 and closes on 23 March 2026.
The price band for Speciality Medicines IPO is set at ₹117.00 to ₹124.00 per share.
The minimum market lot size is 1000 shares. A retail investor can apply for a minimum of 1 lot requiring an investment of 2,000 Shares (₹2,48,000).
The latest Grey Market Premium (GMP) for Speciality Medicines IPO is ₹0.00. GMP represents the unofficial premium at which shares trade prior to listing.
The basis of allotment for Speciality Medicines IPO is tentatively scheduled for TBA, and shares are expected to list on the stock exchanges on 29 March 2026.
The registrar details will be confirmed in the official prospectus.
Speciality Medicines IPO Analysis & Articles
